IAI CONFERENCE: The comparison of the actual cost to case-mix of type 2 diabetes mellitus inpatient in Pandan Arang Boyolali hospital
DOI:
https://doi.org/10.46542/pe.2021.212.269274Keywords:
Actual cost, Cost analysis, Diabetes Mellitus, Factor analysis, INA-CBGsAbstract
Aim: The objective of this study was to determine the conformity of diabetes mellitus (DM) actual cost with the rate of Indonesia Case-Based Groups (INA-CBGs) among Universal Health Coverage (Jaminan Kesehatan Nasional - JKN) and non-JKN patients diagnosed with DM.
Methods: This retrospective cross-sectional study was observational and analytic. It recruited DM inpatients with or without JKN. The data were analysed to identify the total actual cost of DM management among inpatients.
Results: The results showed that the average cost for treating inpatient with diabetes mellitus at classes 1, 2, and 3 was IDR 2,677,003±906,406, IDR 2,881,023±851,483, and IDR 2,323,768±802,828, respectively. A positive difference of 378,509,126 was found between the actual cost and the INA-CBGs rate in 101 patients. There was a discrepancy between the real cost and the INA-CBGs rate for all treatment classes and the treatment levels. Factors influencing the real cost of treatment for DM were the length of stay and the severity level.
References
American Diabetes Association. (2014). Diagnosis and classification of diabetes mellitus. In Diabetes Care (Vol. 37, Issue SUPPL.1). https://doi.org/10.2337/dc14-S081
Asosiation, A. D. (2013). Diagnosis and classification of diabetes mellitus. Diabetes Care, 36(SUPPL.1), 67–74. https://doi.org/10.2337/dc13-S067
Belma Malanda, Suvi Karuranga, Pouya Saeedi, P. S. (2019). IDF Diabetes Atlas Ninth edition 2019. International Diabetes Federation, 1
Eko Wahyu Basuki, Sulistyowati, Retno, N., & Herawati. (2016). Implementasi Kebijakan Jaminan Kesehatan Nasional oleh BPJS Kesehatan di Kota Semarang. Diponegoro Journal Of Social And Political Of Science Tahun 2016, 5(4), 1–11
Feldman, E. L., Callaghan, B. C., Pop-Busui, R., Zochodne, D. W., Wright, D. E., Bennett, D. L., Bril, V., Russell, J. W., & Viswanathan, V. (2019). Diabetic neuropathy. Nature Reviews. Disease Primers, 5(1), 41. https://doi.org/10.1038/s41572-019-0092-1
Finkelstein, E. A., Chay, J., & Bajpai, S. (2014). The economic burden of self-reported and undiagnosed cardiovascular diseases and diabetes on Indonesian households. PLoS ONE, 9(6). https://doi.org/10.1371/journal.pone.0099572
Hein, M., Lanquart, J.-P., Loas, G., Hubain, P., & Linkowski, P. (2018). Prevalence and Risk Factors of Type 2 Diabetes in Major Depression: A Study on 703 Individuals Referred for Sleep Examinations. Psychosomatics, 59(2), 144–157. https://doi.org/10.1016/j.psym.2017.11.003
Islam, Z., & Rusdi, N. K. (2014). Analisis Perbedaan Pengobatan Diabetes Melitus Tipe II pada Pasien Bpjs Dan Pasien Umum the Analysis Different of Treatment Diabetes Mellitus Type Ii on General Patients and National Health Insurance Patients ( Bpjs ). 151–161
Juaella, A. (2013). Analisis Biaya Pengobatan Infeksi Saluran Kemih Pada Pasien Rawat Inap di RSUD Sawerigading Kota Palopo Provinsi Sulawesi Selatan Tahun 2012 (F. F. U. S. Budi (ed.))
Kemenkes. (2014). Peraturan Menteri Kesehatan Republik Indonesia No.28 Tahun 2014 tentang Pedoman Pelakasanaan Program Jaminan Kesehatan Nasional
Kusuma, E., Darmawan, E., & Perwitasari, D. A. (2019). Cost of Illness Diabetes Mellitus Tipe 2 dan Komplikasinya pada Peserta Jaminan Kesehatan Nasional (JKN) di Rawat Jalan Rumah Sakit Condong Catur Yogyakarta Cost of Illness Type 2 Diabetes Mellitus and Its Complications in National Health Insurance at Ou. Farmasi Indonesia, 16(2), 89–101
Labovitz, J. M., Shofler, D. W., & Ragothaman, K. K. (2016). The impact of comorbidities on inpatient Charcot neuroarthropathy cost and utilization. Journal of Diabetes and Its Complications, 30(4), 710–715. https://doi.org/10.1016/j.jdiacomp.2016.01.004
Lubis, I. K., & Susilawati, S. (2018). Analisis Length of Stay (Los) Berdasarkan Faktor Prediktor Pada Pasien DM Tipe II di RS PKU Muhammadiyah Yogyakarta. Jurnal Kesehatan Vokasional, 2(2), 161. https://doi.org/10.22146/jkesvo.30330
Masni, D. (2013). Cost analysis of type 2 diabetes mellitus inpatient hospital RSD of dr Soebandi Jember in the period of 2012. In Thesis. Universitas Setia Budi
Mauvais-Jarvis, F. (2017). Epidemiology of Gender Differences in Diabetes and Obesity. Advances in Experimental Medicine and Biology, 1043, 3–8. https://doi.org/10.1007/978-3-319-70178-3_1
Salim, M. F., Lubis, I. K., & Sugeng, S. (2019). Perbedaan Length of Stay (LOS) Pasien Diabetes Mellitus Berdasarkan Komplikasi Di RSUP Dr. Sardjito Yogyakarta. Jurnal Manajemen Informasi Kesehatan Indonesia, 7(1), 17. https://doi.org/10.33560/jmiki.v7i1.216
Sari, R. P. (2014). Perbandingan biaya riil dengan tarif paket ina ‐ cbg’s dan analisis faktor yang mempengaruhi biaya riil pada pasien. Jurnal Spread, 4(April), 61–70
Wahyuni, N. K. E., L, L. P. F., & Udayani, N. N. W. (2012). Analisis Efektivitas Biaya Penggunaan Terapi Kombinasi Insulin Dan Oho Pada Pasien Diabetes Melitus Tipe 2 Rawat Jalan Di Rsud Wangaya. Dm, 30–37
Yosmar, R., Almasdy, D., & Rahma, F. (2018). Survei Risiko Penyakit Diabetes Melitus Terhadap Masyarakat Kota Padang. Jurnal Sains Farmasi & Klinis, 5(2), 134. https://doi.org/10.25077/jsfk.5.2.134-141.2018
Zheng, Y., Ley, S. H., & Hu, F. B. (2018). Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews. Endocrinology, 14(2), 88–98. https://doi.org/10.1038/nrendo.2017.151
Zhuo, X., Zhang, P., & Hoerger, T. J. (2013). Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. American Journal of Preventive Medicine, 45(3), 253–261. https://doi.org/10.1016/j.amepre.2013.04.017
